[{"uuid": "9bca7b19-6ffd-3d9a-9c8e-06d30a1911db", "title": "ENSC Continues to Announce Potential Life-Changing Results", "publisher": "Zacks Small Cap Research", "link": "https://finance.yahoo.com/news/ensc-continues-announce-potential-life-110600665.html", "providerPublishTime": 1737543960, "type": "STORY", "relatedTickers": ["ENSCW"]}, {"uuid": "026b975b-a3df-3208-878e-5182eef34146", "title": "Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-announces-positive-interim-130000627.html", "providerPublishTime": 1737550800, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "588ab8db-36c8-3fa5-97c8-4973f534322b", "title": "Ensysce Biosciences Issues Annual Shareholder Letter", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-issues-annual-shareholder-130000054.html", "providerPublishTime": 1736341200, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "4002b30c-ef42-3976-bf4e-cf98213729b6", "title": "Ensysce Biosciences Regains Full Compliance with Nasdaq", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-regains-full-compliance-130000804.html", "providerPublishTime": 1734958800, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "eacc439b-a87c-34b2-9ad0-3771584ce013", "title": "Ensysce Biosciences Regains Full Compliance With Nasdaq Listing Rules", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/ensysce-biosciences-regains-full-compliance-163026927.html", "providerPublishTime": 1734971426, "type": "STORY", "relatedTickers": ["ENSCW"]}, {"uuid": "109f7f44-148b-3ee3-a31d-3e8ddbdf656f", "title": "ENSC Improves Position", "publisher": "Zacks Small Cap Research", "link": "https://finance.yahoo.com/news/ensc-improves-position-100000760.html", "providerPublishTime": 1731492000, "type": "STORY", "relatedTickers": ["ENSCW"]}, {"uuid": "6581d284-d5a3-3f16-bec1-30e21ab63930", "title": "Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-announces-commercial-supplier-130000937.html", "providerPublishTime": 1733835600, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "d3fa299f-2fba-31a8-a2ca-9374e9a1c03c", "title": "Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-announces-strategic-partnership-130000121.html", "providerPublishTime": 1733317200, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "827774c6-ba1d-3846-9fd1-bf5f2cef063c", "title": "Ensysce Biosciences Announces 1-for-15 Reverse Stock Split", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-announces-1-15-211500699.html", "providerPublishTime": 1733260500, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "a91ea3c3-2139-3731-8021-9a4b8e10112a", "title": "Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-completes-significant-milestone-130000103.html", "providerPublishTime": 1732626000, "type": "STORY", "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "03495931-4f34-3e36-8c6d-c5ba386b8dc8", "title": "Ensysce Biosciences Third Quarter 2024 Earnings: Beats Expectations", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/ensysce-biosciences-third-quarter-2024-111701408.html", "providerPublishTime": 1731669421, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 945, "height": 636, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NamfX5LEtyScIu4YmRG2hg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "101ec423-a63a-3c08-83b2-592ae236d41b", "title": "Ensysce Biosciences Receives Positive Nasdaq Listing Determination", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-receives-positive-nasdaq-130000164.html", "providerPublishTime": 1730984400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RCg79jJmzkss70AM4eC7Yw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4d23893b9c21b24976465ad00b8660cd", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/seYCxk3qpljSADd9V5.jYA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4d23893b9c21b24976465ad00b8660cd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENSC", "ENSCW"]}, {"uuid": "87cc7c46-0958-3df3-b115-f910883562b7", "title": "Ensysce Biosciences Reports Third Quarter 2024 Financial Results", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/ensysce-biosciences-reports-third-quarter-211500141.html", "providerPublishTime": 1731446100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RCg79jJmzkss70AM4eC7Yw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4d23893b9c21b24976465ad00b8660cd", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/seYCxk3qpljSADd9V5.jYA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4d23893b9c21b24976465ad00b8660cd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENSC", "ENSCW"]}]